Article metrics

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2021

AbstractFullPdf
Nov 202112471225355
Total12471225355